There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Hims & Hers Health Inc (HIMS) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.03, or 0.40%, to $7.50. The Hims & Hers Health Inc has recorded 41,179 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Hims & Hers Health, Inc. Announces $50 Million Share Repurchase Program Authorization.
As a NYSE listed company, HIMS falls under the Consumer Defensive sector while operating within the Household & Personal Products industry segment. At the end of the last regular session, the stock closed at $7.47 and fluctuated between $7.78 as its day high and $7.40 as its day low. The current market capitalization of Hims & Hers Health Inc is $1.58B. A total of 2.35 million shares were traded on the day, compared to an average of 2.41M shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, HIMS has seen 9 BUY and 17 SELL insider trades, representing the acquisition of 365,988 and the disposition of 269,526 shares. Over the last 12 months, there were 79 BUYs and 108 SELLs from insiders. Insiders purchased 4,998,374 shares during that period but sold 14,521,108.
In the most recent transaction, Baird Melissa sold 9,133 shares of HIMS for 7.09 per share on Nov 08. After the transaction, the Chief Operating Officer now owns 403,849 company shares. In a previous transaction on Nov 07, Baird Melissa sold 9,133 shares at 7.07 per share. HIMS shares that Chief Operating Officer owns now total 403,849.
Among the insiders who sold shares, Baird Melissa disposed of 9,133 shares on Nov 06 at a per-share price of $6.34. This resulted in the Chief Operating Officer holding 403,849 shares of HIMS after the transaction. In another insider transaction, Baird Melissa sold 9,133 shares at $6.23 per share on Oct 05. Company shares held by the Chief Operating Officer now total 403,849.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for HIMS in the last 3 months, the mean price target is $10.39 with high estimates of $15.00 and low estimates of $7.00. In terms of 52-week highs and lows, HIMS has a high of $12.34 and a low of $5.61.
As of this writing, HIMS has an earnings estimate of -$0.02 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.01 per share and a lower estimate of -$0.04. The company reported an EPS of -$0.03 in the last quarter, which was 40.00% higher than expectations of -$0.05.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. HIMS’s latest balance sheet shows that the firm has $247.27M in Cash & Short Term Investments as of fiscal 2021. There were $5.48M in debt and $79.22M in liabilities at the time. Its Book Value Per Share was $1.55, while its Total Shareholder’s Equity was $334.62M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HIMS is Buy with a score of 4.10.